S14Y (p.Ser14Tyr) variant of AMH (Anti-Muellerian hormone)
S14Y (p.Ser14Tyr) in AMH (Anti-Muellerian hormone) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.10 / 1. The record also includes population frequency data and structural context.
S14Y (p.Ser14Tyr) variant details
- p.Ser14Tyr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.0985
- REVEL 0.12
- CADD 0.03
- PolyPhen-2 0.09
- SIFT 0.59
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available